Company
as well as continued support from existing investors including affiliates of Nextrans
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| KaliVir Immunotherapeutics | Series A extension | 2026-08-19 |
Company
| Company | Round | Date | Lead |
|---|---|---|---|
| KaliVir Immunotherapeutics | Series A extension | 2026-08-19 |